# OnCo record varsetatug-masetecan (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/varsetatug-masetecan/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "varsetatug-masetecan" ;
  schema:name "Varsetatug masetecan"@en ;
  schema:alternateName "CX-2051"@en, "Varseta-M"@en ;
  schema:description "Varsetatug masetecan is an experimental masked antibody-drug conjugate from CytomX Therapeutics, in phase 1 trials for metastatic colorectal cancer."@en ;
  schema:url <https://onco.cc/drugs/varsetatug-masetecan/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://finviz.com/news/386131/cytomx-therapeutics-announces-fda-fast-track-designation-for-varsetatug-masetecan-varseta-m-for-relapsedrefractory-metastatic-colorectal-cancer-rr-mcrc>, <https://cytomx.com/pipeline/>, <https://clinicaltrials.gov/search?intr=CX-2051> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Masked antibody-drug conjugate (Probody ADC, topoisomerase-1 inhibitor payload)" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:targets <https://onco.cc/targets/epcam/> ;
  onco:companies <https://onco.cc/companies/cytomx-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06265688/>, <https://onco.cc/trials/nct07900165/> .